Company profile
HeroSupport SA
HeroSupport aims to improve cancer treatments effectiveness, safety, cost-efficiency and universal access with personalized patient-positioning medical devices and standardized workflows and services. The initial products are personalized immobilization devices for breast cancer radiotherapy, specifically targeted at prone breast treatment. Other products, such as immobilization for children can be developed.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
